Cargando…
Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses
Despite the importance of the co-receptor PD-1 in T cell immunity, the upstream signaling pathway that regulates PD-1 expression has not been defined. Glycogen synthase kinase 3 (GSK-3, isoforms α and β) is a serine-threonine kinase implicated in cellular processes. Here, we identified GSK-3 as a ke...
Autores principales: | Taylor, Alison, Harker, James A., Chanthong, Kittiphat, Stevenson, Philip G., Zuniga, Elina I., Rudd, Christopher E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760122/ https://www.ncbi.nlm.nih.gov/pubmed/26885856 http://dx.doi.org/10.1016/j.immuni.2016.01.018 |
Ejemplares similares
-
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8(+) Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy
por: Taylor, Alison, et al.
Publicado: (2017) -
Mechanism of glycogen synthase inactivation and interaction with glycogenin
por: Marr, Laura, et al.
Publicado: (2022) -
Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cells
por: Taylor, Alison, et al.
Publicado: (2020) -
Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis
por: Dembowy, J, et al.
Publicado: (2015) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)